Consulting Reports

From Office of Health Economics
Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ().

Access Statistics for this working paper series.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.

001978: Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence

A. Towse and M. Garau

001976: Barriers to Uptake of Minimal Access Surgery in the United Kingdom

Amanda Cole, O'Neill, P., Christopher Sampson and Paula Lorgelly

001944: Review of CRA's Report "Assessing the Economic Impacts of Changing Exemption Provisions During Patent and SPC Protection in Europe"

J. Mestre-Ferrandiz, M. Berdud and A. Towse

001933: Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market

F. Maignen, M. Berdud, G. Hampson and Paula Lorgelly

001932: Routine Funding in the NHS in the UK of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure

B. Zamora, F. Maignen and Paula Lorgelly

001910: Data Governance Arrangements for Real-World Evidence: South Korea

E.k Lee, J.a Park, Amanda Cole and J. Mestre-Ferrandiz

001818: Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries

B. Zamora, F. Maignen, O'Neill, P., J. Mestre-Ferrandiz and M. Garau

001802: Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?

G. Marsden and A. Towse

001784: Policy Options for Formulary Development in Middle-income Countries

K. Hernandez-Villafuerte, M. Garau, A. Towse, L. Garrison and S. Grewal

001781: Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study

K. Hernandez-Villafuerte, M. Garau, T. Towse and L. Garrison

001748: Improving Efficiency and Resource Allocation in Future Cancer Care

Amanda Cole, A. Lundqvist, Paula Lorgelly, H. Norrlid, S. Karlsberg Schaffer, F. Lewis, K. Hernandez-Villafuerte, P. Lindgren, M. Garau, K-O Welin, S. Bianchi, R. Althin, O'Neill, P., U. Persson and A. Towse

001743: Four Case Studies to Explore the Added Value of Oxford AHSN

G. Marsden, A. Martin, B. Zamora, J. Exley, J. Sussex and A. Towse

001699: Shaping Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making

S. Karlsberg Schaffer, Patricia Cubi-Molla, N. Devlin and A. Towse

001688: Assessing Trends in SMC Advice Decisions (October 2009- September 2015)

O'Neill, P. and B. Zamora

001660: Data Governance Arrangements for Real-World Evidence

Amanda Cole, L. Garrison, J. Mestre-Ferrandiz and A. Towse

001645: Estimation of Future Cases of Dementia from Those Born in 2015

F. Lewis

001611: International Comparison of Medicines Usage: Quantitative Analysis from a Swedish Perspective

O'Neill, P. and J. Sussex

001595: Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK

A. Chapman and S. Karlsberg Schaffer

001576: Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?

Koonal Shah, A. Chapman, N. Devlin and P. Barnsley

001504: Obstructive Sleep Apnoea: Health Economics Report

J.c Rejon-Parrilla, M. Garau and J. Sussex

000518: The Trajectory of Dementia in the UK - Making a Difference

F. Lewis, S. Karlsberg Schaffer, J. Sussex, O'Neill, P. and L. Cockcroft

000271: The Many Faces of Innovation

Consulting Ohe

000265: Donor Investment Choices: Modeling the Value for Money of Investing in Product Development, Public Private Parnerships as Compared to Other Health Care and Non-Health Care Interventions

A. Gray, P. Fenn, M. Garau, C. Pritchard, E. Godber and A. Towse

000236: Medical Research: What's It Worth?

Office of Health Economics Health Economics Research Group and Europe Rand

000234: Assessment and Appraisal of Oncology Medicines: NICE's Approach and International HTA Experience

M. Garau, Koonal Shah, A. Towse, Q. Wang, M.f Drummond and A. R. Mason

000229: Forward Together: Complementarity of Public and Charitable Research with Respect to Private Research Spending

J. Mestre-Ferrandiz and J. Sussex

000212: Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe

J. Mestre-Ferrandiz, R. Puig-Peiro and A. Towse

000210: The Publicly Funded Vaccines Market in the UK

J. Sussex and Koonal Shah

000206: The Publicly Funded Vaccines Market in Australia

J. Sussex, Koonal Shah and J. Butler

000203: Assessment of the Impact of Orphan Medicinal Products on the European Economy and Society

J. Mestre-Ferrandiz, M. Garau, O'Neill, P. and J. Sussex

000192: The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response

A. Towse, N. Devlin, E. Hawe and L. Garrison

000187: Exploring the Interdependency between Public and Charitable Medical Research

M. Garau, A. Mordoh and J. Sussex

000169: Time Trends in NICE HTA Decisions

O'Neill, P., N. Devlin and R. Puig-Peiro

000154: The Many Faces of Innovation

J. Mestre-Ferrandiz, A. Mordoh and J. Sussex

000144: International Comparisons of Medicines Prices: 2011 Indices

O'Neill, P., R. Puig-Peiro, J. Mestre-Ferrandiz and J. Sussex

000050: The Expanding Value Footprint of Oncology Treatments

J.c Rejon-Parrilla, K. Hernandez-Villafuerte, Koonal Shah, J. Mestre-Ferrandiz, L. Garrison and A. Towse

000001: Health and the Use of Medicines in Primary Care in Wales

L. Baillie, E. Hawe, O'Neill, P. and R. Greville